Coronary artery atherosclerosis is the major cause of mortality and morbidity in the
industrialised world. Progressive narrowing of coronary arteries causes angina. However, it …

Objectives This study sought to investigate the postdeployment expansion and
malapposition characteristics of the bioresorbable vascular scaffold (BVS) in real‐world …

Background Post–percutaneous coronary intervention (PCI) fractional flow reserve≥ 0.90 is
an accepted marker of procedural success, and a cutoff of≥ 0.95 has recently been …

Background Adenosine is used to treat no‐reflow in the infarct‐related artery (IRA) during ST‐
segment–elevation myocardial infarction intervention. However, the physiological effect of …

Background Available data on the use of the ABSORB bioresorbable vascular scaffold
(BVS)(Abbott Vascular, Santa Clara, CA) in real-world patients is limited. The aim of this …

Background The incretin hormone glucagon-like peptide 1 (GLP-1) has been shown to
protect against lethal ischemia-reperfusion injury in animal models and against nonlethal …

Background Incretin therapies appear to provide cardioprotection and improve
cardiovascular outcomes in patients with diabetes, but the mechanism of this effect remains …

Background Rotational atherectomy (RA) is an established treatment of heavily-calcified
coronary stenoses. Previous data suggest higher procedural complication rates when Burr …

Background Suboptimal metallic stent expansion may be associated with increased instent
restenosis, TVR & stent thrombosis. Manufacturers' compliance charts relate implanted stent …

Introduction Prior studies have shown that virtual-histology intravascular ultrasound (VH-
IVUS) identified thin-capped fibroatheroma (VHTCFA)(figure 1) and plaque burden (PB)> …